Parkinson’’s disease: diagnostic relevance of elevated levels of soluble αα-synuclein oligomers in cerebrospinal fluid

By Mukaetova-Ladinska Elizabeta B  

Future Neurology, Vol. 6, Iss. 2, 2011-03 ,pp. : 159-163

Future Medicine

Access to resources Recommend Favorite

A Comparative Study on Neurochemistry of Cerebrospinal Fluid in Advanced Parkinson's Disease

By Liu H.   Iacono R.P.   Schoonenberg T.   Kuniyoshi S.   Buchholz J.  

Neurobiology of Disease, Vol. 6, Iss. 1, 1999-02 ,pp. : 35-42

Academic Press

Access to resources Recommend Favorite

Longitudinal assessment of tau and amyloid beta in cerebrospinal fluid of Parkinson disease

By Zhang Jing   Mattison Hayley   Liu Changqin   Ginghina Carmen   Auinger Peggy   McDermott Michael   Stewart Tessandra   Kang Un   Cain Kevin   Shi Min  

Acta Neuropathologica, Vol. 126, Iss. 5, 2013-11 ,pp. : 671-682

Springer Publishing Company

Access to resources Recommend Favorite

Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects

By Maarouf Chera L   Beach Thomas G   Adler Charles H   Shill Holly A   Sabbagh Marwan N   Wu Terence   Walker Douglas G   Kokjohn Tyler A   Roher Alex E   PD Consortium Arizona  

Neurological Research, Vol. 34, Iss. 7, 2012-09 ,pp. : 669-676

Maney Publishing

Access to resources Recommend Favorite

Cytotoxicity of ventricular cerebrospinal fluid from Parkinson patients: Correlation with clinical profiles and neurochemistry

By Mandybur George T.   Miyagi Yasushi   Yin Wei   Perkins Eddie   Zhang John H.  

Neurological Research, Vol. 25, Iss. 1, 2003-01 ,pp. : 104-111

Maney Publishing

Access to resources Recommend Favorite